LobbyingFigs lobbying by quarter
Figs's latest lobbying report covers Q2 2026, at $120K. The four quarters Q4 2025–Q3 2026 total $360K. Its first report covers Q4 2022; the issues it reports most are Health Issues.
FigsFIGS
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $360K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $50K | 1 |
| Q1 2023 | $120K | 2 |
| Q2 2023 | $120K | 2 |
| Q3 2023 | $120K | 2 |
| Q4 2023 | $120K | 2 |
| Q1 2024 | $120K | 3 |
| Q2 2024 | $120K | 2 |
| Q3 2024 | $120K | 2 |
| Q4 2024 | $120K | 2 |
| Q1 2025 | $120K | 2 |
| Q2 2025 | $120K | 2 |
| Q3 2025 | $120K | 2 |
| Q4 2025 | $120K | 2 |
| Q1 2026 | $120K | 2 |
| Q2 2026 | $120K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$1.7M · 30 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES30 reports
- SENATE30 reports
- White House Office6 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseFigs | $980K | 14 quarters |
| Venable | $500K | 10 quarters |
| Capitol Counsel | $250K | 6 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| TIMOTHY URSPRUNG | Staff Assistant, Rep. Peter King; Legislative Correspondent, Rep. Peter King; Legislative Assistant, Rep. Peter King | Q1 2025 |
| LUKE HATZIS | LD & LA, Cong. Peter Roskam; Republican Clerk, House Rules Committee; Legislative Aide, House Republican Conference; Floor Assistant, Speaker J. Dennis Hastert. | Q3 2023 |
| JOHN MARTIN | Principal Associate Commissioner, FDA; Legislative Director, Sen. Tom Cotton; Legislative Assistant; Sen. Tom Cotton; Legislative Assistant, Representative Tom Cotton. | Q2 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/22for Q2 | In-house | $70K |
| 07/14for Q2 | Venable | $50K |
| 04/21for Q1 | In-house | $70K |
| 04/14for Q1 | Venable | $50K |
| 01/21for Q4 2025 | In-house | $70K |
| 01/13for Q4 2025 | Venable | $50K |
| 25/11/06for Q3 2025 | In-house | $70K |
| 25/10/16for Q3 2025 | Venable | $50K |
| 25/07/15for Q2 2025 | Venable | $50K |
| 25/07/14for Q2 2025 | In-house | $70K |
| 25/04/15for Q1 2025 | Venable | $50K |
| 25/04/10for Q1 2025 | In-house | $70K |
| 25/01/22for Q4 2024 | In-house | $70K |
| 25/01/21for Q4 2024 | Venable | $50K |
| 24/10/18for Q3 2024 | Venable | $50K |
| 24/10/18for Q3 2024 | In-house | $70K |
| 24/07/23for Q2 2024 | In-house | $70K |
| 24/07/18for Q2 2024 | Venable | $50K |
| 24/04/24for Q1 2024 | In-house | $70K |
| 24/04/22for Q1 2024 | Venable | $50K |